Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential
Authors
Keywords
-
Journal
Therapeutic Advances in Musculoskeletal Disease
Volume 5, Issue 5, Pages 277-285
Publisher
SAGE Publications
Online
2013-09-20
DOI
10.1177/1759720x13501021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- The rapid onset of multiple squamous cell carcinomas in two patients commenced on ustekinumab as treatment of psoriasis
- (2012) Lauren Young et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection
- (2012) T.-F. Tsai et al. BRITISH JOURNAL OF DERMATOLOGY
- Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis
- (2012) Shiu-Chung Au et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Reversible Posterior Leukoencephalopathy Syndrome in a Patient Treated With Ustekinumab
- (2011) David Gratton ARCHIVES OF DERMATOLOGY
- Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies
- (2011) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Population pharmacokinetics of ustekinumab in patients with active psoriatic arthritis
- (2011) Y.W. Zhu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: A phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)
- (2011) Tsen-Fang Tsai et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: Long-term results from a phase 2/3 clinical trial
- (2011) Atsuyuki IGARASHI et al. JOURNAL OF DERMATOLOGY
- Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial
- (2010) Arthur Kavanaugh et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
- (2009) Alice Gottlieb et al. LANCET
- Investigation of association of the IL12B and IL23R genes with psoriatic arthritis
- (2008) Charlotte Filer et al. ARTHRITIS AND RHEUMATISM
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Polymorphisms of the IL12B and IL23R Genes Are Associated with Psoriasis
- (2008) Rajan P. Nair et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started